Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

ATN 114 is a cross-sectional substudy of ATN 106. In addition to sharing data collected in
ATN 106, an oral rinse sample along with the subject's self reported history and medical
chart abstraction of HPV vaccination status and medical chart abstraction of a history of
oral condylomata, oral dysplasia and oral tumor viruses will be collected in ATN 114.

Recruitment is expected to last approximately one year, similar to the same timeframe for
ATN 106. Enrollment may be terminated earlier at the discretion of the ATN Executive
Committee and/or the ATN 114 protocol team should ATN 106 also terminate enrollment early.
Individuals who have agreed to participate in ATN 106 may be simultaneously approached at
any clinic visit, or, for community-based sites, contacted directly for participation in ATN
114. Site staff may also contact individuals via phone, e-mail, or any other agreed-upon
methods of communication. Site staff should try as much as possible to incorporate the study
visit into a regularly scheduled clinic visit.

Inclusion Criteria

- Behaviorally acquired HIV-infection as indicated by medical chart abstraction or
self-reported history of sexual risk and/or needle using behaviors; and

- Completion of the ATN 106 study visit (the same day or up to a maximum of 14 calendar
days).

Exclusion Criteria

- Presence of serious psychiatric symptoms (e.g., active hallucinations, thought
disorder) that would impair the individual's ability to complete the study measures;

- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior); or

- Intoxicated or under the influence of alcohol or other substances at the time of
consent/assent for ATN 114.